Four new cases of measles in Fayette County; eight now tied to Central KY outbreak
As of July 7, there were eight confirmed cases of the highly contagious measles virus connected to an outbreak in Woodford and Fayette counties, Lexington-Fayette County Health Department officials said Monday.
That includes four new cases in Fayette County, all of which are tied to the first Fayette County case. Those who got the virus were considered household contacts.
'These individuals have been under quarantine since the initial case was identified, and there is no known additional risk to the public from these cases,' health officials said in a Monday news release.
In addition to the Central Kentucky outbreak, an unrelated measles case was confirmed in Todd County on June 27.
In total, Kentucky has reported 11 measles cases in 2025.
The Lexington-Fayette County Health Department is continuing to respond to the outbreak.
The health department continues to work closely with the Kentucky Department for Public Health and other local partners to investigate cases, ensure appropriate quarantine protocols and notify those who may have been exposed.
In a previous Herald-Leader article, Kentucky Health and Family Services Secretary Dr. Steven Stack described the spread as 'not surprising' given the wider measles outbreak across the country. This year, the U.S. Centers for Disease Control and Prevention has reported more than 1,200 measles cases across multiple states.
The department is encouraging everyone to verify their vaccination status and ensure they are protected. The measles, mumps, and rubella (MMR) vaccine is a safe and effective way to prevent infection.
Adults born after 1957 should have documentation of at least one dose of MMR vaccine, and children should receive two doses: the first at 12-15 months and the second at 4-6 years of age.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Enzo Health Forms Advisory Board of Industry Titans to Drive Innovation in Home-Based Care
LEHI, Utah, July 08, 2025--(BUSINESS WIRE)--Enzo Health, the AI-powered automation platform redefining how home health agencies deliver and document care, today announced the formation of its Advisory Board. This influential group unites nationally acclaimed experts in home health operations, clinical excellence, healthcare regulation, and digital health innovation. The creation of the Advisory Board marks a significant milestone in Enzo Health's mission to empower home health organizations by streamlining workflows, reducing administrative burdens, and enhancing patient outcomes through automation. As providers face rising clinical acuity, workforce shortages, and complex regulatory demands, these distinguished advisors will provide strategic counsel on product innovation, clinical accuracy, and market growth. "We are on a mission to liberate every role in the home health ecosystem, from field clinicians to administrative and billing teams," said Zach Newman, Co-Founder and CEO of Enzo Health. "By automating tedious, manual tasks, we enable providers to operate at their highest level of expertise and increase capacity to serve more people. Our Advisory Board members bring unmatched insight and leadership to help us build solutions that are practical, scalable, and deeply aligned with clinical reality." Meet the Enzo Health Advisory Board Bud Langham, PT, MBA Former Executive Vice President, Enhabit Home Health & Hospice A seasoned healthcare executive with a legacy of clinical innovation, Bud Langham previously served as an Executive Vice President at Enhabit where he held roles focused on clinical excellence, innovation, and strategy. With more than two decades of healthcare leadership experience, Bud has advanced home-based care across national platforms. He joins Enzo Health to accelerate its vision for transformative, data-driven care delivery. Renee Picard Walsh Founder, RPW Consulting A proven leader in healthcare operations and growth strategy, Renee Picard Walsh brings a 30 year track record of scaling organizations for impact. As former Senior Vice President at Byram Healthcare, an Owen's & Minor Company and Co-Founder/President of ClinLogica, she has led strategic planning initiatives that improve outcomes and operational resilience. Her expertise in home value based care will be instrumental in guiding Enzo Health's expansion and commitment to patient-first innovation. Beau Sorenson COO First Choice Home Health & Hospice Beau Sorensen, Chief Operating Officer of First Choice Home Health & Hospice, is a distinguished industry leader with over 25 years of progressive experience. Under his leadership as COO since 2012, First Choice achieved CMS 5-star agency status through innovative technology initiatives and operational excellence. A nationally recognized advocate, Beau serves on multiple advisory boards including the Home Health Financial Managers Association and National Association for Home Care & Hospice, actively shaping industry policy and educational initiatives nationwide. Annette Lee Founder and President, Provider Insights, Inc. Annette Lee brings over 20 years of unparalleled expertise in home health and hospice compliance, quality improvement, and regulatory strategy. Having spent a decade with a Medicare Administrative Contractor (MAC), Annette provided critical oversight and guidance on Medicare reimbursement, policy interpretation, and regulatory compliance specifically for home health and hospice organizations. A nationally respected educator and advisor, she is renowned for her ability to translate complex policy into actionable clinical practice. Her deep Medicare expertise and strategic insight significantly strengthen Enzo Health's commitment to clarity, compliance, and care excellence. Accelerating Healthcare Innovation Through Partnership As the pace of change in healthcare intensifies, Enzo Health is committed to building a future where technology empowers providers rather than overwhelms them. The formation of this Advisory Board reflects the company's dedication to listening deeply to clinical and operational voices while delivering cutting-edge solutions that are practical, scalable, and outcome-focused. The new Advisory Board will play an essential role in ensuring that Enzo Health's platform evolves to meet the real-world needs of providers across the country, helping agencies achieve better outcomes, drive efficiency, and stay ahead of regulatory shifts. About Enzo Health Enzo Health is a healthcare technology company pioneering automation solutions that empower home health providers to focus on delivering exceptional patient care. Founded by healthcare and technology leaders, Enzo Health combines clinical insight with intelligent automation to address the most pressing challenges in care delivery. Its platform streamlines documentation, reduces administrative burden, and enhances quality. Founded by seasoned clinicians and technologists and backed by world-class healthcare investors, Enzo Health is re-engineering home-based care so every visit delivers exceptional outcomes. To learn more about Enzo Health or book a demo, visit View source version on Contacts Enzo Health Technology, Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22 minutes ago
- Yahoo
Some of those who supported Trump have concerns about what's in his megabill
Some Trump supporters living in rural areas say they have concerns about the impact of President Donald Trump's tax and policy megabill, which he signed into law on Friday. The bill's potential health care impacts, both personally and on their communities, were top of mind for some, while others anticipated a positive impact on business but were wary of the bill's price tag. ABC News spoke with these people after the Senate passed the bill on July 1 but before the House did two days later. Provisions in the bill enacting stricter eligibility requirements for Medicaid could impact finances for rural hospitals, which tend to rely more on Medicaid funding than urban hospitals and often already operate on tight margins. The American Hospital Association called the potential impact on rural hospitals and patients 'devastating.' In the leadup to the bill's passage, Democratic senators working with researchers from the University of North Carolina Chapel Hill compiled a list of 338 rural hospitals that could be at risk of 'financial distress,' 'service reductions' or closure. Some Republican senators, including Sen. Bill Cassidy, R-La., a physician, and Sen. Susan Collins, R-Maine, had expressed concerns about the bill impacting health care providers in their states. In response to these worries, Senate Republicans included a measure setting aside $50 billion over five years in the bill to support these rural hospitals, but advocates and experts say it may not be enough to prevent hospital shutdowns and loss of care. The National Rural Health Association said in a statement that the fund would 'fall short of' offsetting the impact of other provisions. James, a 62-year-old man who lives in a semi-rural area in North Carolina, is on Medicaid and gets Supplemental Nutrition Assistance Program (SNAP) benefits. He said the bill would cut around $300 worth of those benefits for him per month. 'It's going to be hard to pay the rent and everything else,' he said. He added that he didn't have family that could help support him, now that his brother has died and his mother was in a nursing home. MORE: How soon will you feel the effects of Trump's megabill? Identifying as an independent, James said he did not vote in 2024 but had liked Trump as a candidate more than Democratic nominee Kamala Harris. 'I thought Trump was the lesser of two evils,' he said. 'But I was wrong … If you want to make the poor people poorer, he's doing real good.' Insurance agent Bryan Shaver, who lives in Hattiesburg, Mississippi, voted for Trump in 2024. Shaver, 62, said he was not worried about the Medicaid provisions in the bill affecting his clients. 'Because they're elderly and they make very little money,' he was confident they would meet the new criteria. However, Shaver said he was 'absolutely worried' that the Medicaid cuts could affect rural hospitals in Mississippi, some of which he had worked with in the past. 'It was extremely difficult for them to take care of who they needed to take care of … it's very difficult for them to survive in Mississippi,' Shaver said. He said hospitals' financial struggles sometimes reduced access to care for the people living around them. 'A lot of the hospitals here can't afford [to provide care for] maternity,' Shaver said. 'For example, a hospital up in Batesville, Mississippi. [Patients] have to drive to Memphis to deliver a baby, and that's kind of ridiculous.' Shaver said he would wait to see how the provisions in the bill would affect voters. If there was a negative impact, he said he hoped Republican lawmakers would 'correct it' or otherwise 'get booted out.' Stephen Caraway, who also voted for Trump, lives in a rural area around 70 miles east of Cincinnati. He said he anticipated a positive effect for himself and his community from the bill. Caraway was appointed to the state's Elections Commission by Ohio Governor Mike Dewine in 2023 and will serve until 2027. 'There are service jobs, a lot of restaurant positions in my part of Ohio, and I absolutely think that no tax on tips or overtime would be great for the middle class and for those employees,' Caraway said. He said he would personally benefit from some of the tax cuts the bill extended. To Caraway, the tightened eligibility requirements for Medicaid seemed reasonable, and he did not buy into worries that the bill would take millions of people off the benefits and potentially hurt rural hospitals like the one he lives near. Caraway's one concern is the effect the bill would have on U.S. debt. The Congressional Budget Office estimates that it would add $3.4 trillion to the deficit over a decade. MORE: Why some economists say the deficit increase in Trump's bill is dangerous 'Regardless of what party was in control, I would tell you that the federal government needs an overhaul, and has needed it for a long time. The only thing that would give me pause is some of those CBO projections,' Caraway said. 'But I believe that those projections can just as easily be incorrect as they can be correct. And I'm going to trust my national leaders to do what is right and be fiscally responsible.'
Yahoo
28 minutes ago
- Yahoo
Breast cancer vaccine breakthrough as more than 75% of women show immune response in new test
A breakthrough breast cancer vaccine has completed Phase one trials, with over 75 percent of participants showing a strong immune response, raising hopes it could help eradicate the disease by 2030. The vaccine, developed by Anixa Biosciences and the Cleveland Clinic, targets alpha‑lactalbumin, a milk protein linked to aggressive triple-negative breast cancer, to help prevent and treat the disease. That form of cancer is known as the most deadly. During the first phase of the trial, 35 women, many with triple-negative breast cancer or a genetic risk, received the vaccine. Blood tests showed that more than 75 percent developed a strong immune response, indicated by antibodies on their white blood cells. That improved response can help a person's immune system identify and destroy cancerous cells. Side effects of the vaccine were limited to mild injection‑site irritation. Dr. Amit Kumar, Anixa's CEO, called the findings 'very exciting' in an interview with the New York Post. 'It's a very new mechanism and we think that if this works and is able to prevent cancer, then we can perhaps eliminate breast cancer as a disease, just like we've done for polio and various other infectious diseases,' Kumar told the outlet. Phase two is scheduled for next year and will test a larger group of participants and expand testing to additional types of breast cancer. Unlike vaccines for infections, cancer vaccines face challenges because cancer originates from the body's own cells, making it harder for the immune system to distinguish them. Past attempts often targeted proteins found in both cancerous and healthy tissues, sometimes causing harmful immune responses. Breast cancer cells often contain alpha-lactalbumin, a protein normally only present during pregnancy and breastfeeding. A Cleveland Clinic scientist proposed targeting it in women not planning to have more children 20 years ago, leading to the current vaccine trial. The US Department of Defense funded the study, but future progress may be affected by budget cuts. Researchers plan to present their results to the agency this year.
